International Journal of Endocrinology and Metabolism

Published by: Kowsar
Corrected Proof scheduled for 16 (4)

Human Prolactinoma: A View of Protein-Protein Interaction Pattern

Mona Zamanian Azodi 1 , Majid Rezaei-Tavirani 2 , Mohammad Rostami Nejad 3 and Mostafa Rezaei-Tavirani 4 , *
Authors Information
1 Student Research Committee, Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
3 Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Endocrinology and Metabolism: , In Press (In Press); e67332
  • Published Online: August 6, 2018
  • Article Type: Research Article
  • Received: February 10, 2018
  • Revised: June 23, 2018
  • Accepted: July 21, 2018
  • DOI: 10.5812/ijem.67332

To Cite: Zamanian Azodi M, Rezaei-Tavirani M, Rostami Nejad M, Rezaei-Tavirani M . Human Prolactinoma: A View of Protein-Protein Interaction Pattern, Int J Endocrinol Metab. Online ahead of Print ;In Press(In Press):e67332. doi: 10.5812/ijem.67332.

Abstract
Copyright © 2018, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Liu Y, Wu J, Yan G, Hou R, Zhuang D, Chen L, et al. Proteomic analysis of prolactinoma cells by immuno-laser capture microdissection combined with online two-dimensional nano-scale liquid chromatography/mass spectrometry. Proteome Sci. 2010;8:2. doi: 10.1186/1477-5956-8-2. [PubMed: 20205839]. [PubMed Central: PMC2825229].
  • 2. Ciccarelli A, Daly AF, Beckers A. The epidemiology of prolactinomas. Pituitary. 2005;8(1):3-6. doi: 10.1007/s11102-005-5079-0. [PubMed: 16411062].
  • 3. Seltzer JA, Scotton TC, Carmichael JD, Zada G. Gene and protein expression in prolactinomas. Late Break Neuroendocrinol Pituitar III Endocrin Societ. 2015;19(1):LBS-81-LBS.
  • 4. Giorgianni F, Koirala D, Beranova-Giorgianni S. Proteomics of the human pituitary tissue: bioanalytical methods and applications. Bioanal. 2014;6(14):1989-2003.
  • 5. Zhan X, Desiderio DM. Signaling pathway networks mined from human pituitary adenoma proteomics data. BMC Med Genomics. 2010;3:13. doi: 10.1186/1755-8794-3-13. [PubMed: 20426862]. [PubMed Central: PMC2884164].
  • 6. Evans CO, Moreno CS, Zhan X, McCabe MT, Vertino PM, Desiderio DM, et al. Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses. Pituitary. 2008;11(3):231-45. doi: 10.1007/s11102-007-0082-2. [PubMed: 18183490].
  • 7. Zhan X, Wang X, Cheng T. Human pituitary adenoma proteomics: new progresses and perspectives. Frontier Endocrinol. 2016;7:54. doi: 10.3389/fendo.2016.00054.
  • 8. Tong Y, Zheng Y, Zhou J, Oyesiku NM, Koeffler HP, Melmed S. Genomic characterization of human and rat prolactinomas. Endocrinology. 2012;153(8):3679-91. doi: 10.1210/en.2012-1056. [PubMed: 22635680]. [PubMed Central: PMC3404356].
  • 9. Rezaei-Tavirani M, Rezaei-Taviran S, Mansouri M, Rostami-Nejad M, Rezaei-Tavirani M. Protein-protein interaction network analysis for a biomarker panel related to human esophageal adenocarcinoma. Asian Pac J Cancer Prev. 2017;18(12):3357-63. doi: 10.22034/APJCP.2017.18.12.3357. [PubMed: 29286604]. [PubMed Central: PMC5980895].
  • 10. Valizadeh R, Monfared AB, Rezaei–Tavirani M, Mansouri V. Evaluation of involved proteins in colon adenocarcinoma: an interactome analysis. Gastroenterol Hepatol Bed Bench. 2017;10(Suppl1). S129.
  • 11. Azodi MZ, Tavirani MR, Oskouie AA, Hamdieh M, Derakhshan MK, Ahmadzadeh A. Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach. Iran J Pharmaceut Res: IJPR. 2017;16(3):1264.
  • 12. Abdolahi H, Azodi MZ. Protein interaction mapping interpretation of none alcoholic fatty liver disease model of rats after fat diet feeding. Gastroenterol Hepatol Bed Bench. 2017;10(Suppl1). S146.
  • 13. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207-10. [PubMed: 11752295]. [PubMed Central: PMC99122].
  • 14. Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007;23(14):1846-7. doi: 10.1093/bioinformatics/btm254. [PubMed: 17496320].
  • 15. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498-504. doi: 10.1101/gr.1239303. [PubMed: 14597658]. [PubMed Central: PMC403769].
  • 16. Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362-8. doi: 10.1093/nar/gkw937. [PubMed: 27924014]. [PubMed Central: PMC5210637].
  • 17. Assenov Y, Ramirez F, Schelhorn SE, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics. 2008;24(2):282-4. doi: 10.1093/bioinformatics/btm554. [PubMed: 18006545].
  • 18. Abbaszadeh HA, Peyvandi AA, Sadeghi Y, Safaei A, Zamanian-Azodi M, Khoramgah MS, et al. Er:YAG Laser and Cyclosporin A Effect on Cell Cycle Regulation of Human Gingival Fibroblast Cells. J Lasers Med Sci. 2017;8(3):143-9. doi: 10.15171/jlms.2017.26. [PubMed: 29123635]. [PubMed Central: PMC5662504].
  • 19. Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25(8):1091-3. doi: 10.1093/bioinformatics/btp101. [PubMed: 19237447]. [PubMed Central: PMC2666812].
  • 20. Pala NA, Laway BA, Misgar RA, Dar RA. Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline. Diabetol Metab Syndr. 2015;7:99. doi: 10.1186/s13098-015-0094-4. [PubMed: 26583049]. [PubMed Central: PMC4650139].
  • 21. Yang C, Liu L, Lan X, Zhang S, Li X, Zhang B. Progressive visual disturbance and enlarging prolactinoma caused by melanoma metastasis. Med. 2017;96(14). e6483. doi: 10.1097/md.0000000000006483.
  • 22. Maghvan PV, Rezaei–Tavirani M, Zali H, Nikzamir A, Abdi S, Khodadoostan M. Network analysis of common genes related to esophageal, gastric, and colon cancers. Gastroenterol Hepatol Bed Bench. 2017;10(4):295.
  • 23. Erem C, Kocak M, Nuhoglu I, Yılmaz, M , Ucuncu, O . Blood coagulation, fibrinolysis and lipid profile in patients with prolactinoma. Clinical Endocrinol. 2010;73(4):502-7.
  • 24. O'Connor DT, Burton D, Deftos LJ. Chromogranin a: immunohistology reveals its universal occurrence in normal polypeptide hormone producing endocrine glands. Life Sci. 1983;33(17):1657-63. doi: 10.1016/0024-3205(83)90721-x.
  • 25. Mauras N, Rogol AD, Haymond MW, Veldhuis JD. Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty. Horm Res. 1996;45(1-2):74-80. doi: 10.1159/000184763. [PubMed: 8742123].
  • 26. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656-60. doi: 10.1038/45230. [PubMed: 10604470].
  • 27. Abel MH, Wootton AN, Wilkins V, Huhtaniemi I, Knight PG, Charlton HM. The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. Endocrinology. 2000;141(5):1795-803. doi: 10.1210/endo.141.5.7456. [PubMed: 10803590].
  • 28. Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst. 2002;94(13):972-80. [PubMed: 12096082].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments